Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Endocrine ; 49(3): 809-19, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25586874

RESUMO

We analyzed the effects of chemically blocking type 1 muscarinic receptors (M1R) on either the left or right ovary on ovulation rate, number of ova shed and steroid hormones levels. M1R were unilaterally blocked in ovary with the M1R selective antagonist pirenzepine (PZP). PZP was delivered into the bursa ovarica of the left or right ovary of adult rats at 13:00 h on proestrus day. PZP treatment in the left but not in the right ovary blocked ovulation. PZP did not modify the number of ova shed, nor progesterone or 17ß-estradiol serum levels. The surge of luteinizing hormone levels was diminished while that of follicle-stimulating hormone did not change in animals treated with PZP in the left ovary. Interestingly, treatment with either synthetic luteinizing hormone-releasing hormone or human chorionic gonadotropin 1 h after PZP administration in the left ovary restored ovulation in both ovaries. The presence of M1R protein in the theca cells of the ovarian follicles as well as in cells of the corpus luteum was detected on proestrus day. These results suggest that M1R activation in the left ovary is required for pre-ovulatory gonadotropin-releasing hormone (GnRH) secretion and ovulation. Furthermore, these results also suggest that M1R in the left ovary might be regulating ovulation asymmetrically through a stimulatory neural signal relayed to the hypothalamus via the vagus nerve to induce the GnRH secretion which then triggers ovulation.


Assuntos
Ovário/metabolismo , Ovulação/fisiologia , Proestro/fisiologia , Receptor Muscarínico M1/metabolismo , Animais , Estradiol/sangue , Feminino , Hormônio Foliculoestimulante/sangue , Hormônio Liberador de Gonadotropina/farmacologia , Hipotálamo/metabolismo , Hormônio Luteinizante/sangue , Antagonistas Muscarínicos/farmacologia , Folículo Ovariano/metabolismo , Ovulação/efeitos dos fármacos , Pirenzepina/farmacologia , Proestro/efeitos dos fármacos , Progesterona/sangue , Ratos , Receptor Muscarínico M1/efeitos dos fármacos , Células Tecais , Vagotomia
2.
Diabetologia ; 55(6): 1808-12, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22460760

RESUMO

AIMS/HYPOTHESIS: Increased NEFA levels, characteristic of type 2 diabetes mellitus, contribute to skeletal muscle insulin resistance. While NEFA-induced insulin resistance was formerly attributed to decreased glycolysis, it is likely that glucose transport is the rate-limiting defect. Recently, the plant-derived sugar alcohol xylitol has been shown to have favourable metabolic effects in various animal models. Furthermore, its derivative xylulose 5-phosphate may prevent NEFA-induced suppression of glycolysis. We therefore examined whether and how xylitol might prevent NEFA-induced insulin resistance. METHODS: We examined the ability of xylitol to prevent NEFA-induced insulin resistance. Sustained ~1.5-fold elevations in NEFA levels were induced with Intralipid/heparin infusions during 5 h euglycaemic-hyperinsulinaemic clamp studies in 24 conscious non-diabetic Sprague-Dawley rats, with or without infusion of xylitol. RESULTS: Intralipid infusion reduced peripheral glucose uptake by ~25%, predominantly through suppression of glycogen synthesis. Co-infusion of xylitol prevented the NEFA-induced decreases in both glucose uptake and glycogen synthesis. Although glycolysis was increased by xylitol infusion alone, there was minimal NEFA-induced suppression of glycolysis, which was not affected by co-infusion of xylitol. CONCLUSIONS/INTERPRETATION: We conclude that xylitol prevented NEFA-induced insulin resistance, with favourable effects on glycogen synthesis accompanying the improved insulin-mediated glucose uptake. This suggests that this pentose sweetener has beneficial insulin-sensitising effects.


Assuntos
Ácidos Graxos não Esterificados/farmacologia , Resistência à Insulina/fisiologia , Xilitol/farmacologia , Animais , Transporte Biológico/efeitos dos fármacos , Diabetes Mellitus Tipo 2/prevenção & controle , Glucose/metabolismo , Masculino , Ratos , Ratos Sprague-Dawley
3.
Eur J Biochem ; 263(3): 797-805, 1999 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10469144

RESUMO

The coordinated interaction of kinases, phosphatases and other regulatory molecules with scaffolding proteins is emerging as a major theme in intracellular signaling networks. In this report we show that a cDNA isolated from a rat testis expression library by interactive cloning using the regulatory subunit (R) of a type-II protein kinase A (PKA) is identical with a previously characterized protein kinase C (PKC)-binding protein termed either clone 72 [Chapline, C., Mousseau, B., Ramsay, K., Duddy, S., Li, Y., Kiley, S. C. & Jaken, S. (1996) J. Biol. Chem. 271, 6417-6422] or SSeCKS [Lin, X., Tombler, E., B., Nelson, P.J., Ross, M. & Gelman, I.H. (1996) J. Biol. Chem. 271, 28430-28438]. Deletion mutagenesis demonstrated that amino acids 1495-1524 of clone 72/SSeCKS had the ability to interact with RII. Antibodies prepared against the recombinant protein recognized a 280/290-kDa doublet and a 240-kDa protein on Western blots of rat testis cytosolic and Triton X-100 extracts. Expression of clone 72/SSeCKS mRNA and protein levels was developmentally regulated in rat testis. Northern-blot analysis showed a dramatic increase in clone 72/SSeCKS-hybridizing mRNA starting 30 days after birth. Immunohistochemical examination showed high expression levels in elongating spermatids. Clone 72/SSeCKS was not detected in mature sperm. These studies suggest a role for clone 72/SSeCKS, a PKA/PKC scaffolding protein, during the process of spermiogenesis.


Assuntos
Envelhecimento/metabolismo , Proteínas de Ciclo Celular , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Regulação da Expressão Gênica no Desenvolvimento , Mitógenos/genética , Espermatogênese/fisiologia , Testículo/metabolismo , Proteínas de Ancoragem à Quinase A , Animais , Autoantígenos/genética , Clonagem Molecular , Proteína Quinase Tipo II Dependente de AMP Cíclico , Proteínas Quinases Dependentes de AMP Cíclico/genética , DNA Complementar , Biblioteca Gênica , Masculino , Mitógenos/metabolismo , Mutagênese Sítio-Dirigida , Proteínas/genética , RNA Mensageiro/genética , Ratos , Ratos Sprague-Dawley , Proteínas Recombinantes/metabolismo , Deleção de Sequência , Testículo/crescimento & desenvolvimento , Transcrição Gênica
4.
Int J Biochem ; 25(5): 725-9, 1993 May.
Artigo em Inglês | MEDLINE | ID: mdl-8349014

RESUMO

1. It has been shown that adenosine stimulates glycolysis in some cells and this ability of adenosine was tested in the hypoxic guinea pig heart. 2. Adenosine (10 microM) activated lactate production in the isolated perfused guinea pig heart under conditions of normoxia but did not under hypoxia. 3. Despite this, the nucleoside favorably influenced the energy metabolism of the hypoxic heart as revealed by the better posthypoxic functional recovery (98%) compared to the control without adenosine (78%). 4. Our findings suggest a role for the glycolytic pathway in this effect of the nucleoside as long as other cardiac energy-yielding pathways are strictly aerobic.


Assuntos
Adenosina/farmacologia , Coração/efeitos dos fármacos , Hipóxia/metabolismo , Lactatos/metabolismo , Piruvatos/metabolismo , Animais , Cobaias , Técnicas In Vitro , Ácido Láctico , Miocárdio/metabolismo , Ácido Pirúvico
5.
Int J Biochem ; 24(3): 433-6, 1992 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-1532368

RESUMO

1. Adenosine increases the adenine nucleotide pool in rat erythrocytes. Hence, we tested the effect of the nucleoside on the glycolytic pathway in red blood cells. 2. A 2.5-fold increase in the level of fructose-1,6-bisphosphate and a 34% augmentation in lactate pool were observed in rat erythrocytes, 30 min after adenosine treatment. 3. Under conditions preventing adenosine metabolism, 1 microM nucleoside addition to isolated erythrocytes induced an 89% increase in lactate production and an increase in glucose consumption. 4. Activation of red cell phosphofructokinase (PFK) is produced by addition of microM concentrations of adenosine. Our data suggest a role for adenosine in the glycolysis flux regulation through PFK activation.


Assuntos
Adenosina/farmacologia , Eritrócitos/metabolismo , Glicólise/efeitos dos fármacos , Animais , Ativação Enzimática/efeitos dos fármacos , Frutosedifosfatos/sangue , Cinética , Lactatos/sangue , Ácido Láctico , Masculino , Fosfofrutoquinase-1/sangue , Ratos , Ratos Endogâmicos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...